Stock Fundamentals

Company Information

▼
Company Name
ProKidney Corp.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: KYG7S53R1049
CIK: 0001850270
Currency: USD
Full Time Employees: 204
Phone: 336 999 7028
Website: https://prokidney.com
Fiscal Year End: December
IPO Date: Jul 12, 2022
Description:

ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States. Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes. The company also develops a cryopreserved version of rilparencel that allows for long-term product preservation to be used in Phase 2 and 3 trials of rilparencel. ProKidney Corp. was founded in 2015 and is headquartered in Winston-Salem, North Carolina.

Address:

2000 Frontis Plaza Blvd., Winston-Salem, NC, United States, 27103

Directors & Officers

▼
Name Title Year Born
Dr. Bruce Culleton M.D. CEO & Director 1968
Dr. Ulrich Ernst Ph.D. EVP of Science and Technology 1963
Mr. Todd C. Girolamo Esq., J.D., M.B.A. Chief Legal Officer & Secretary 1965
Mr. James Coulston CPA Chief Financial Officer 1977
Ms. Anu Biswas Senior VP of Manufacturing & Operations NA
Mr. Richard Williams Chief Information Officer NA
Ms. Carla Poulson Chief People Officer NA
Dr. Joseph M. Stavas M.D., M.P.H. SVP of Clinical Affairs NA
Dr. Darin J. Weber Ph.D. Chief Reg. Off, SVP and Head of Global Reg. Affairs, Quality Mgmt, Biometrics & Market Access 1968
Mr. Nikhil L. Pereira-Kamath Chief Business Officer NA

Institutional Holders

▼
Holder Name Shares Date Reported % Out Value % Change
Suvretta Capital Management, LLC 12.34M Dec 31, 2025 9.53% $0.57 0.00%
Morgan Stanley - Brokerage Accounts 6.75M Sep 30, 2025 5.21% $0.00 0.00%
Bleichroeder LP 2.00M Sep 30, 2025 1.54% $0.94 0.00%
Millennium Management LLC 1.96M Sep 30, 2025 1.51% $0.00 0.00%
Artia Global Partners LP 1.84M Dec 31, 2025 1.42% $0.58 0.00%
Vanguard Group Inc 1.65M Dec 31, 2025 1.27% $0.00 5.38%
BlackRock Inc 1.28M Sep 30, 2025 0.99% $0.00 0.00%
Geode Capital Management, LLC 1.10M Sep 30, 2025 0.85% $0.00 0.00%
Hennion & Walsh Asset Management Inc 919.90K Sep 30, 2025 0.71% $0.08 0.00%
Renaissance Technologies Corp 895.71K Dec 31, 2025 0.69% $0.00 578.56%
Bank of America Corp 660.86K Sep 30, 2025 0.51% $0.00 0.00%
Charles Schwab Investment Management Inc 623.11K Dec 31, 2025 0.48% $0.00 -4.59%
UBS Group AG 508.35K Sep 30, 2025 0.39% $0.00 0.00%
Woodline Partners LP 500.00K Dec 31, 2025 0.39% $0.00 0.00%
State Street Corp 474.96K Sep 30, 2025 0.37% $0.00 0.00%
Two Sigma Investments LLC 465.51K Dec 31, 2025 0.36% $0.00 368.88%
MYDA Advisors LLC 440.00K Dec 31, 2025 0.34% $0.19 -2.22%
Squarepoint Ops LLC 351.42K Dec 31, 2025 0.27% $0.00 1.99%
Citadel Advisors Llc 344.79K Sep 30, 2025 0.27% $0.00 0.00%
Susquehanna International Group, LLP 255.00K Sep 30, 2025 0.20% $0.00 0.00%

Shares Statistics

▼
Shares Outstanding: 141.55M
Shares Float: 93.27M
% Insiders: 2,538.40%
% Institutions: 3,458.70%
Short % Float: 15.75%

🏆 Top 10 Institutional Holders

▼
Rank Holder Name Shares Held % of Shares Change Date Reported
1 Suvretta Capital Management, LLC 12.34M 9.53% ▲ 0.00% Dec 31, 2025
2 Morgan Stanley - Brokerage Accounts 6.75M 5.21% ▲ 0.00% Sep 30, 2025
3 Bleichroeder LP 2.00M 1.54% ▲ 0.00% Sep 30, 2025
4 Millennium Management LLC 1.96M 1.51% ▲ 0.00% Sep 30, 2025
5 Artia Global Partners LP 1.84M 1.42% ▲ 0.00% Dec 31, 2025
6 Vanguard Group Inc 1.65M 1.27% ▲ 5.38% Dec 31, 2025
7 BlackRock Inc 1.28M 0.99% ▲ 0.00% Sep 30, 2025
8 Geode Capital Management, LLC 1.10M 0.85% ▲ 0.00% Sep 30, 2025
9 Hennion & Walsh Asset Management Inc 919.90K 0.71% ▲ 0.00% Sep 30, 2025
10 Renaissance Technologies Corp 895.71K 0.69% ▲ 578.56% Dec 31, 2025

Valuation Metrics

▼
Enterprise Value: $50.99M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $673.87M
EBITDA: $-164.58M
Book Value: $-7.41
Earnings/Share: $-0.55
Profit Margin: 0.00%
Operating Margin: -17,613.36%
ROA (TTM): -25.85%
ROE (TTM): -41.81%
Revenue (TTM): $744.00K
Revenue/Share (TTM): $0.01
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios (Yearly)

▼

Financial Ratios (Quarterly)

▼

Earnings History

▼

Balance Sheet (Yearly)

▼

Financial Ratios

▼
Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 10.93x 0.00x 0.09x -20,408.44x 0.00x
2023-12-31 14.94x 0.00x 0.07x -12,626.83x -0.01x
2022-12-31 46.42x 0.00x 0.03x -711.66x 0.00x
2021-12-31 2.21x 0.01x 0.33x -27,555.00x -0.01x
2020-12-31 1.02x 0.02x 0.41x -628.47x -0.01x
2019-12-31 5.68x 0.01x 0.19x N/A -0.01x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Nov 13, 2025 Brian Jg Pereira N/A Sale 502.14K $2.37 $1.19M
Nov 12, 2025 Brian Jg Pereira N/A Sale 255.03K $2.72 $693.67K
Jul 08, 2025 Darin J. Weber N/A Sale 103.48K $3.02 $312.51K
Apr 22, 2025 Control Empresarial De Capital N/A Purchase 387.39K $0.71 $275.05K
Apr 16, 2025 Control Empresarial De Capital N/A Purchase 100.00K $0.75 $75.00K
Apr 14, 2025 Control Empresarial De Capital N/A Purchase 268.11K $0.73 $195.72K
Apr 10, 2025 Control Empresarial De Capital N/A Purchase 1.03M $0.61 $629.65K

📦 Raw API Data (JSON Explorer)

▼

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PROK.US!